Your browser doesn't support javascript.
loading
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy.
Darwich, Adam S; Polasek, Thomas M; Aronson, Jeffrey K; Ogungbenro, Kayode; Wright, Daniel F B; Achour, Brahim; Reny, Jean-Luc; Daali, Youssef; Eiermann, Birgit; Cook, Jack; Lesko, Lawrence; McLachlan, Andrew J; Rostami-Hodjegan, Amin.
Afiliación
  • Darwich AS; Logistics and Informatics in Health Care, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, SE-141 57 Huddinge, Sweden.
  • Polasek TM; Department of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, South Australia 5000, Australia.
  • Aronson JK; Centre for Medicine Use and Safety, Monash University, Melbourne, Victoria 3052, Australia.
  • Ogungbenro K; Certara, Princeton, New Jersey 08540, USA.
  • Wright DFB; Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, United Kingdom.
  • Achour B; Centre for Applied Pharmacokinetic Research, The University of Manchester, Manchester M13 9PT, United Kingdom; email: amin.rostami@manchester.ac.uk.
  • Reny JL; School of Pharmacy, University of Otago, Dunedin 9054, New Zealand.
  • Daali Y; Centre for Applied Pharmacokinetic Research, The University of Manchester, Manchester M13 9PT, United Kingdom; email: amin.rostami@manchester.ac.uk.
  • Eiermann B; Geneva Platelet Group, Faculty of Medicine, University of Geneva, CH-1211 Geneva, Switzerland.
  • Cook J; Division of General Internal Medicine, Geneva University Hospitals, CH-1211 Geneva, Switzerland.
  • Lesko L; Geneva Platelet Group, Faculty of Medicine, University of Geneva, CH-1211 Geneva, Switzerland.
  • McLachlan AJ; Inera AB, Swedish Association of Local Authorities and Regions, SE-118 93 Stockholm, Sweden.
  • Rostami-Hodjegan A; Drug Safety Research & Development, Pfizer Inc., Groton, Connecticut 06340, USA.
Annu Rev Pharmacol Toxicol ; 61: 225-245, 2021 01 06.
Article en En | MEDLINE | ID: mdl-33035445
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Desarrollo de Medicamentos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Annu Rev Pharmacol Toxicol Año: 2021 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Desarrollo de Medicamentos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Annu Rev Pharmacol Toxicol Año: 2021 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos